Dual Orexin Antagonists (Quviviq/Daridorexant)

Type: drug

Status: FDA/EMA Approved

Developer: Idorsia

Breakthrough Summary

No summary available.

Mechanism of Action

Blocks orexin receptors to promote natural sleep without next-day hangover

Year: 2022+